Oncoinvent ASA
Kaldvik AS engages in the salmon farming business in Iceland. It also operates smolt stations. The company was incorporated in 2020 and is headquartered in Eskifjörður, Iceland. Kaldvik AS was formerly known as Ice Fish Farm AS and changed its name to Kaldvik AS in August 2024. Kaldvik AS operates as a subsidiary of Austur Holding As.
Oncoinvent ASA (KLDVK) - Total Assets
Latest total assets as of December 2025: Nkr507.79 Million NOK
Based on the latest financial reports, Oncoinvent ASA (KLDVK) holds total assets worth Nkr507.79 Million NOK as of December 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Oncoinvent ASA - Total Assets Trend (2021–2025)
This chart illustrates how Oncoinvent ASA’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Oncoinvent ASA - Asset Composition Analysis
Current Asset Composition (December 2025)
Oncoinvent ASA's total assets of Nkr507.79 Million consist of 29.9% current assets and 70.1% non-current assets.
| Asset Category | Amount (NOK) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Nkr0.00 | 2.5% |
| Accounts Receivable | Nkr6.57 Million | 1.3% |
| Inventory | Nkr132.68 Million | 26.1% |
| Property, Plant & Equipment | Nkr0.00 | 0.0% |
| Intangible Assets | Nkr198.43 Million | 39.1% |
| Goodwill | Nkr0.00 | 0.0% |
Asset Composition Trend (2021–2025)
This chart illustrates how Oncoinvent ASA's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Oncoinvent ASA's current assets represent 29.9% of total assets in 2025, an increase from 25.9% in 2021.
- Cash Position: Cash and equivalents constituted 2.5% of total assets in 2025, up from 0.4% in 2021.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 39.0% of total assets, an increase from 37.0% in 2021.
- Asset Diversification: The largest asset category is intangible assets at 39.1% of total assets.
Oncoinvent ASA Competitors by Total Assets
Key competitors of Oncoinvent ASA based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Astra Agro Lestari Tbk
JK:AALI
|
Indonesia | Rp30.51 Trillion |
|
CHUWIT FARM (2019) PUBLIC COMPANY LIMITED
BK:CFARM
|
Thailand | ฿883.86 Million |
|
ShenZhen Kondarl Group Co Ltd
SHE:000048
|
China | CN¥10.49 Billion |
|
Hunan Zhenghong Science and Technology Develop Co Ltd
SHE:000702
|
China | CN¥505.58 Million |
|
Hefei Fengle Seed Co Ltd
SHE:000713
|
China | CN¥3.52 Billion |
|
Luoniushan Co Ltd
SHE:000735
|
China | CN¥10.05 Billion |
|
New Hope Liuhe Co Ltd
SHE:000876
|
China | CN¥116.87 Billion |
|
Yuan Longping High-tech Agriculture Co Ltd
SHE:000998
|
China | CN¥25.48 Billion |
Oncoinvent ASA - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Oncoinvent ASA generates 0.22x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Oncoinvent ASA is currently not profitable relative to its asset base.
Oncoinvent ASA - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 5.43 | 2.77 | 3.21 |
| Quick Ratio | 0.69 | 0.27 | 0.36 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | Nkr123.94 Million | Nkr 96.67 Million | Nkr 125.39 Million |
Oncoinvent ASA - Advanced Valuation Insights
This section examines the relationship between Oncoinvent ASA's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.25 |
| Latest Market Cap to Assets Ratio | 0.02 |
| Asset Growth Rate (YoY) | 5.2% |
| Total Assets | Nkr507.79 Million |
| Market Capitalization | $10.48 Million USD |
Valuation Analysis
Below Book Valuation: The market values Oncoinvent ASA's assets below their book value (0.02 x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Oncoinvent ASA's assets grew by 5.2% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Oncoinvent ASA (2021–2025)
The table below shows the annual total assets of Oncoinvent ASA from 2021 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | Nkr507.79 Million | +5.25% |
| 2024-12-31 | Nkr482.47 Million | +12.87% |
| 2023-12-31 | Nkr427.47 Million | +37.22% |
| 2022-12-31 | Nkr311.53 Million | +81.62% |
| 2021-12-31 | Nkr171.53 Million | -- |